LeMaitre Vascular Ownership
LMAT Stock | USD 83.49 2.19 2.56% |
Shares in Circulation | First Issued 2004-03-31 | Previous Quarter 22.8 M | Current Value 22.9 M | Avarage Shares Outstanding 17.1 M | Quarterly Volatility 4.4 M |
LeMaitre |
LeMaitre Stock Ownership Analysis
About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.23. LeMaitre Vascular last dividend was issued on the 13th of March 2025. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people. To find out more about LeMaitre Vascular contact George LeMaitre at 781 221 2266 or learn more at https://www.lemaitre.com.Besides selling stocks to institutional investors, LeMaitre Vascular also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different LeMaitre Vascular's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align LeMaitre Vascular's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
LeMaitre Vascular Quarterly Liabilities And Stockholders Equity |
|
LeMaitre Vascular Insider Trades History
About 9.0% of LeMaitre Vascular are currently held by insiders. Unlike LeMaitre Vascular's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against LeMaitre Vascular's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of LeMaitre Vascular's insider trades
LeMaitre Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as LeMaitre Vascular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LeMaitre Vascular backward and forwards among themselves. LeMaitre Vascular's institutional investor refers to the entity that pools money to purchase LeMaitre Vascular's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Northern Trust Corp | 2024-12-31 | 327.8 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 284.8 K | Driehaus Capital Management Llc | 2024-12-31 | 263.2 K | Envestnet Asset Management Inc | 2024-12-31 | 259.4 K | Acadian Asset Management Llc | 2024-12-31 | 236.8 K | Rice Hall James & Associates, Llc | 2024-12-31 | 235.1 K | Goldman Sachs Group Inc | 2024-12-31 | 206.6 K | Charles Schwab Investment Management Inc | 2024-12-31 | 195.8 K | Kayne Anderson Rudnick Investment Management Llc | 2024-12-31 | 193.1 K | Blackrock Inc | 2024-12-31 | 3.9 M | Conestoga Capital Advisors, Llc | 2024-12-31 | 1.7 M |
LeMaitre Vascular Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LeMaitre Vascular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
LeMaitre Vascular Outstanding Bonds
LeMaitre Vascular issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LeMaitre Vascular uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LeMaitre bonds can be classified according to their maturity, which is the date when LeMaitre Vascular has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
LeMaitre Vascular Corporate Filings
F3 | 21st of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 14th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.